The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility

Biological Chemistry

Volumn 383, Issue 1, 2002, Pages 5-19

  Kjøller, Lars ^a  

^a FINSEN LABORATORY   (Denmark)

Author keywords

Activation; Adhesion; Integrins; Plasminogen; Proteases; Signal transduction; Vitronectin

Indexed keywords

ACTIN; INTEGRIN; MEMBRANE PROTEIN; UROKINASE; UROKINASE RECEPTOR; VITRONECTIN; CELL SURFACE RECEPTOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS;

CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; CYTOSKELETON; ENZYME BINDING; EXTRACELLULAR MATRIX; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; PHYSIOLOGY;

ACTINS; ANIMALS; CELL MOVEMENT; CYTOSKELETON; HUMANS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 0037622867     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.002     Document Type: Review

References (147)

1. A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2
2. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo
3. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling
4. Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways
5. The urokinase-type plasminogen activator system in cancer metastasis: A review
6. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor
7. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes
8. Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK
9. The urokinase receptor
10. A urokinase receptor-associated protein with specific collagen binding properties
11. Rho GTPases and their effector proteins
12. The urokinase receptor. A cell surface, regulated chemokine
13. Urokinase plasminogen activator receptor, β 2-integrins, and Src- kinases within a single receptor complex of human monocytes
14. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility
15. Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells
16. Urokinase receptor interacts with α(v)β5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer
17. Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration
18. FGF-2 stimulates migration of Kaposi's sarcoma-like vascular cells by HGF-dependent relocalization of the urokinase receptor
19. Protease crosstalk with integrins: The urokinase receptor paradigm
20. Regulation of cell contraction and membrane ruffling by distinct signals in migratory cells
21. Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence
22. Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT-1080 cells
23. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity
24. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2
25. Plasminogen activators, tissue degradation, and cancer
26. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion
27. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA
28. Src-dependence and pertussis-toxin sensitivity of urokinase receptor- dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
29. Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways
30. Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes
31. Urokinase-urokinase receptor interaction: Non-mitogenic signal transduction in human epidermal cells
32. Generation and characterization of urokinase receptor-deficient mice
33. Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells
34. Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells
35. The urokinase receptor associated protein (uPARAP/endo 180): A novel internalization receptor connected to the plasminogen activation system
36. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes
37. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity
38. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells
39. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor
40. The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility
41. Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility
42. The biology of cell locomotion within three-dimensional extracellular matrix
43. Integrin signaling
44. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway
45. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-β1
46. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction
47. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN
48. Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils
49. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
50. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection
51. Rho GTPases and the actin cytoskeleton
52. pp60(c-src) is required for cell locomotion regulated by the hyaluronanreceptor RHAMM
53. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex
54. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation
55. The intact urokinase receptor is required for efficient vitronectin binding: Receptor cleavage prevents ligand interaction
56. Suppression of integrin activation: A novel function of a Ras/Raf-initiated MAP kinase pathway
57. Microdomains in lymphocyte signalling: Beyond GPI-anchored proteins
58. Dedicated myosin light chain kinases with diverse cellular functions
59. The urokinase receptor is a major vitronectin-binding protein on endothelial cells
60. Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders
61. Tumor invasion as dysregulated cell motility
62. Protein kinase C and the cytoskeleton
63. Proximity oscillations of complement type 4 (αX β2) and urokinase receptors on migrating neutrophils
64. Activation of Rac1 by a Crk SH3-binding protein, DOCK180
65. Signaling to Rho GTPases
66. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin
67. Regulation of cell motility by mitogen-activated protein kinase
68. CAS/Crk coupling serves as a 'molecular switch' for induction of cell migration
69. Nerve growth factor and neurotrophin-3 promote chemotaxis of mouse macrophages in vitro
70. Mitogenic effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor
71. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598
72. Mechanisms of signaling through urokinase receptor and the cellular response
73. Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction
74. Cell migration: A physically integrated molecular process
75. Blockage of urokinase receptor reduces in vitro the motility and the deformability of endothelial cells
76. Cytoskeletal reorganization by G protein-coupled receptors is dependent on phosphoinositide 3-kinase γ, a Rac guanosine exchange factor, and Rac
77. The hunting of the Src
78. Urokinase receptor (CD87) regulates leukocyte recruitment via β 2 integrins in vivo
79. The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer
80. Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation
81. Actin-based cell motility and cell locomotion
82. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis
83. Mechanisms for pro matrix metalloproteinase activation
84. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface
85. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
86. i-coupled receptors
87. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility
88. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner
89. Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells
90. Rho GTPases control polarity, protrusion, and adhesion during cell movement
91. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines
92. Purified α 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the α 2-macroglobulin receptor mediates cellular degradation of receptor-bound complexes
93. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
94. Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction
95. Integrin signalling: A new Cas(t) of characters enters the stage
96. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity
97. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion
98. Urokinase receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth
99. New aspects of integrin signaling in cancer
100. Focal adhesion kinase: A regulator of focal adhesion dynamics and cell movement
101. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol
102. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor
103. Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts
104. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells
105. Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon
106. Urokinase receptor: A molecular organizer in cellular communication
107. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
108. Mutant mice with scrambled brains: Understanding the signaling pathways that control cell positioning in the CNS
109. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
110. Proteolytic control of growth factor availability
111. Other neurotrophic factors: Glial cell line-derived neurotrophic factor (GDNF)
112. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: Summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events
113. Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor
114. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells
115. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function
116. Lipid rafts and signal transduction
117. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes
118. Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes
119. Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils
120. Cutting edge: Evidence for a signaling partnership between urokinase receptors (CD87) and L-selectin (CD62L) in human polymorphonuclear neutrophils
121. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro
122. Melanoma cell migration on vitronectin: Regulation by components of the plasminogen activation system
123. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes
124. Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck/Fgr deficient macrophages
125. Gp130 and the interleukin-6 family of cytokines
126. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells
127. Signaling by distinct classes of phosphoinositide 3-kinases
128. A cellular binding site for the Mr 55.000 form of the human plasminogen activator, urokinase
129. Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells
130. Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: A role for Src family kinases
131. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy
132. Nonproteolytic role for the urokinase receptor in cellular migration in vivo
133. Urokinase receptor mediates mechanical force transfer across the cell surface
134. i-mediated inhibition of adenylate cyclase and extracellular-regulated kinases
135. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth
136. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro
137. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion
138. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth
139. Identification of the urokinase receptor as an adhesion receptor for vitronectin
140. Regulation of integrin function by the urokinase receptor
141. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling
142. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by α2-macroglobulin receptor associated protein
143. Localization of urokinase type plasminogen activator to focal adhesions requires ligation of vitronectin integrin receptors
144. Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro
145. Urokinase-type plasminogen activator receptors associate with β1 and β3 integrins of fibrosarcoma cells: Dependence on extracellular matrix components
146. Modulatory role of ERK MAPK-caldesmon pathway in PDGF-stimulated migration of cultured pulmonary artery SMCs
147. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction